Business Trends– category –
-
Antares and Novartis Forge $1.9B Deal to Tackle ‘Undruggable’ Cancer Targets with Small Molecules
Business Wire USA Overview Antares Therapeutics and Novartis have announced a strategic collaboration to discover, develop, and commercialize first-in-class small molecule therapies for previously 'undruggable' cancer targets. The agreem... -
Biogen Pivots Post-Apellis Acquisition: Halts Most R&D, Concentrates on Commercial Assets
Endpoints News USA Overview Biogen has confirmed it will suspend or terminate "most" of Apellis Pharmaceuticals' research programs and lay off some employees following its $5.6 billion acquisition. This strategic pivot is part of integra... -
BMS Reveals Promising Clinical Data for Next-Gen Blood Cancer Therapy Mezigdomide
BioPharma Dive USA Overview Bristol Myers Squibb (BMS) unveiled promising new clinical data for mezigdomide, its next-generation blood cancer therapy. This drug is one of two key protein degradation inducers BMS expects to succeed its mu... -
Novartis’ Acquired RNA Therapeutic del-brax Achieves Phase 1/2 Success for Muscle-Wasting Diseases
BioPharma Dive USA Overview Novartis' RNA therapeutic del-brax, acquired through its $12 billion purchase of Avidity Pharmaceuticals, successfully completed a Phase 1/2 clinical trial for muscle-wasting diseases, achieving its primary en... -
Major Setback: Pfizer’s Seagen-Acquired ADC Fails Phase 3 in Advanced Lung Cancer
BioPharma Dive USA Overview Pfizer's antibody-drug conjugate (ADC), sigvotatug vedotin, acquired through its Seagen acquisition, failed to meet its primary endpoint of improved overall survival (OS) in a Phase 3 clinical trial for patien... -
Breaking the Blood-Brain Barrier: Next-Gen Strategies Unveil Neurological Drug Delivery Innovation
Pharmaceutical Conferences 2026 International会議 Overview A recent conference on June 22, 2026, showcased groundbreaking drug delivery strategies designed to circumvent the formidable blood-brain barrier (BBB). These innovations, includ... -
Factorial Energy Secures Pilot Manufacturing Contract with Tier 1 Auto Supplier for Semi-Solid Batteries
PR Newswire USA Overview Factorial Energy, a developer of semi-solid-state battery technology, has secured a new pilot manufacturing contract with a Tier 1 automotive supplier for its proprietary cells. This agreement will facilitate the... -
Volkswagen Accelerates Solid-State Battery Integration, Initiates QuantumScape A-Sample Testing
Handelsblatt Germany Overview Volkswagen has reaffirmed its commitment to solid-state battery technology by announcing an acceleration of its joint venture with QuantumScape. The automaker confirmed plans for extensive testing of Quantum... -
CATL Pours Over $2 Billion into Semi-Solid Battery Production Expansion, Targeting 2028 Operation
Reuters China Overview Chinese battery behemoth CATL announced substantial new investments exceeding $2 billion to significantly expand its production capacity for semi-solid-state batteries. This strategic expansion aims to meet surging... -
Solid Power Confirms Gen2 Solid-State Cell Production for BMW and Ford Automotive Qualification
GlobeNewswire USA Overview Solid Power has provided an update on its Gen2 all-solid-state battery cell development, confirming consistent production from its pilot line for ongoing automotive qualification testing with BMW and Ford. Inte...
